S-nitrosothiols loaded mini-sized Au@silica nanorod elicits collagen depletion and mitochondrial damage in solid

Ping Liu1, Yidan Wang1, Yang Liu2

  • 1Tianjin Key Laboratory of Drug Delivery & High-Efficiency, School of Pharmaceutical Science and Technology, Tianjin University, 300072, Tianjin, P. R. China.

Theranostics
|June 20, 2020
PubMed

Insights

This study introduces novel nanoparticles that release nitric oxide (NO) to break down tumor extracellular matrix (ECM), improving nanomedicine delivery and cancer treatment. The nanoparticles also enable dual imaging for precise tumor monitoring.

Area of Science:

  • Nanotechnology
  • Biomedical Engineering
  • Oncology

Background:

  • Dense tumor extracellular matrix (ECM) hinders nanoparticle delivery and efficacy in cancer therapy.
  • Overcoming ECM barriers is crucial for deep nanomedicine penetration and enhanced treatment outcomes.

Purpose of the Study:

  • To develop a collagen-depleting nanosweeper (GSNP-TPP) for enhanced nanoparticle penetration and cancer treatment.
  • To investigate the nitric oxide (NO)-releasing capabilities of S-nitrosothiols for ECM modification and theranostics.

Main Methods:

  • Fabrication of mini-sized Au@silica nanorods loaded with S-nitrosothiols and coated with triphenylphosphonium bromide (TPP).
  • Evaluation of collagen depletion via western blotting and immunofluorescent staining.
  • Assessment of dual-imaging (CT/MSOT) and antitumor efficacy in a HeLa tumor-bearing mouse model.

Main Results:

  • Released NO depleted collagen by activating matrix metalloproteinases (MMPs), loosening the ECM and enhancing cellular uptake.
  • Mitochondrial-targeted NO generated peroxynitrite (ONOO-), inducing apoptosis and enhancing antitumor effects.
  • GSNP-TPPs demonstrated effective computed tomography (CT) and multi-spectral optoacoustic tomography (MSOT) imaging for tumor localization and monitoring.

Conclusions:

  • The developed GSNP-TPP nanoparticles offer a strategy to overcome nanoparticle penetration barriers in solid tumors.
  • This approach enhances nanomedicine delivery and antitumor efficacy through ECM remodeling and targeted apoptosis induction.
  • The study highlights the potential of NO-related theranostic systems for advanced cancer treatment.